Zosano Pharma Corp., of Fremont, Calif., said it issued and sold an additional 750,000 shares of common stock, pursuant to the exercise in full of the underwriter's option in connection with Zosano's public offering. A total of 5.75 million shares of common stock have now been sold, resulting in net proceeds of about $18.4 million.